Fidson Healthcare Plc (NGX:FIDSON)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
136.50
0.00 (0.00%)
At close: May 26, 2026
Market Cap327.60B +524.7%
Revenue (ttm)126.65B +26.2%
Net Income11.19B +69.3%
EPS4.61 +59.8%
Shares Out 2.40B
PE Ratio29.61
Forward PE20.04
Dividend1.50 (1.10%)
Ex-Dividend DateApr 15, 2026
Volume371,402
Openn/a
Previous Close136.50
Day's Rangen/a
52-Week Range27.85 - 136.50
Beta0.56
Analystsn/a
Price Targetn/a
Earnings DateJul 28, 2026

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, capsules, syrups, tablets, and injectables. The company also provides products for anti-infective and anti-malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in ... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 732
Stock Exchange Nigerian Stock Exchange
Ticker Symbol FIDSON
Full Company Profile

Financial Performance

In 2025, Fidson Healthcare's revenue was 119.06 billion, an increase of 41.42% compared to the previous year's 84.19 billion. Earnings were 9.88 billion, an increase of 124.68%.

Financial Statements